Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 11, 2019 07:00 ET | Source: Recro Pharma, Inc.

Recro Pharma Announces Five-Year Manufacturing and Supply Agreement Between Novartis and Recro Gainesville

Company Continues Long-Term, Strategic Relationship with Key Customer Recro Gainesville to be Exclusive Supplier of Ritalin LA® and Focalin XR® Capsules with “Total Revenue Per Capsule Economics”...
January 02, 2019 07:00 ET | Source: Recro Pharma, Inc.

Recro Pharma Amends Athyrium Credit Facility

New Terms Provide for Continued Access to $40 Million in Debt Funding $10 Million of the $40 Million Funded at Closing MALVERN, Pa., Jan. 02, 2019 (GLOBE NEWSWIRE) -- Recro Pharma, Inc....
December 21, 2018 07:00 ET | Source: Recro Pharma, Inc.

Recro Pharma Amends IV Meloxicam License Agreement with Alkermes

MALVERN, Pa., Dec. 21, 2018 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (NASDAQ:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for the hospital and other acute care...
December 10, 2018 07:00 ET | Source: Recro Pharma, Inc.

Recro Pharma Announces Presentation of New Data Demonstrating IV Meloxicam’s Effect on Platelet Function at the 72nd PostGraduate Assembly in Anesthesiology

MALVERN, Pa., Dec. 10, 2018 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (NASDAQ:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for the hospital and other acute care...
November 14, 2018 07:00 ET | Source: Recro Pharma, Inc.

Recro Pharma Announces Publication of Phase II IV Meloxicam Abdominal Hysterectomy Data in Anesthesia & Analgesia

MALVERN, Pa., Nov. 14, 2018 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (NASDAQ:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for the hospital and other acute care...
November 08, 2018 07:00 ET | Source: Recro Pharma, Inc.

Recro Pharma to Participate in Upcoming Investor Conferences

MALVERN, Pa., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (NASDAQ:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for the hospital and other acute care...
November 07, 2018 07:00 ET | Source: Recro Pharma, Inc.

Recro Pharma Reports Third Quarter 2018 Financial Results Raising Guidance for CDMO business for 2018

Company to Host Conference Call Today at 8:00 AM ET MALVERN, Pa., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (NASDAQ:REPH), a revenue generating specialty pharmaceutical company focused...
October 31, 2018 07:00 ET | Source: Recro Pharma, Inc.

Recro Pharma to Report Third Quarter 2018 Financial Results and Host Conference Call and Webcast on November 7, 2018

Conference Call and Webcast Scheduled for Wednesday, November 7, 2018 at 8:00 a.m. ET MALVERN, Pa., Oct. 31, 2018 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (NASDAQ:REPH), a revenue generating...
October 08, 2018 07:00 ET | Source: Recro Pharma, Inc.

Recro Pharma Announces PDUFA Date for IV Meloxicam

MALVERN, Pa., Oct. 08, 2018 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (NASDAQ:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for the hospital and other acute care...
October 01, 2018 07:00 ET | Source: Recro Pharma, Inc.

Recro Announces Expansion of CDMO Service Capabilities

MALVERN, Pa., Oct. 01, 2018 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (NASDAQ:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for the hospital and other acute care...